canSAR.ai
Click to visit website
About
canSAR.ai is a public, integrated knowledge-base for cancer drug discovery, powered by an international collaboration led by MD Anderson Cancer Center. It brings together multidisciplinary data across biology, chemistry, pharmacology, structural biology, cellular networks, and clinical annotations. Crucially, it applies machine learning and artificial intelligence to provide drug-discovery useful predictions. The platform offers tools like Chemical Search and Advanced Search for proteins, cell lines, drugs, diseases, and 3D structures. It serves as a single portal for complex multi-disciplinary questions, aiding hypothesis generation and decision-making in identifying causes, biomarkers, and therapeutics for cancer. It is freely available to all researchers.
Platform
Task
Features
• free and publicly available resource
• regularly updated multidisciplinary data (e.g., 3d structures, protein families)
• offers tools for analyzing tissue/cell line expression and structural data
• provides detailed insights on proteins, drugs, and their interactions
• advanced search across various biological and chemical entities
• chemical search (substructure and similarity)
• leverages ai/ml for drug-discovery predictions
• integrated knowledge-base for cancer drug discovery
FAQs
What is canSAR?
canSAR.ai is an integrated database that brings together biological, chemical, pharmacological (and eventually clinical) data to aid cancer research.
Do I need a license to use canSAR?
No, canSAR.ai is freely available to all cancer researchers, both academic and commercial.
Why is canSAR.ai called 'canSAR.ai'?
The name 'canSAR' is a historical play on words reflecting its integration of cancer-relevant data with compound Structure-Activity-Relationship (SAR) data.
I seem to find that some functionality is missing when using IE
Internet Explorer (IE) is a non-standards compliant browser. Use Microsoft Edge or other modern browsers for full functionality.
How can I inform you of any bugs or problems?
Please email us on cansar@mdanderson.org to report any bugs or issues you experience while using canSAR.
How can I cite canSAR?
You can cite canSAR using the publication: "canSAR: update to the cancer translational research and drug discovery knowledgebase" published in Nucl. Acids Res. in 2023.
Where does the data in canSAR.ai come from?
canSAR.ai data comes from a wide variety of public sources and publications. Internal versions also include internally generated experimental data.
How often is the data in canSAR.ai updated?
Data is generally updated on a monthly basis, but public sources have different cycles. The Data Sources page shows update status.
How frequently is the 3D structural data updated in canSAR?
3D structures are updated every week, a couple of days after PDB releases new structures, with additional annotations.
Do I need to know the official gene name to search for a target?
No, canSAR.ai searches all alternative names, synonyms, descriptions, and keywords.
What organisms does canSAR.ai store data on?
canSAR.ai focuses on human data for targets, but includes many model organism targets. Chemical screening data is from various organisms.
I still cannot find my target and I have searched for different names
Try expanding the search with "Advanced Search" and "All organisms." If still not found, try a sequence search or email cansar@mdanderson.org.
I cannot find a compound by searching for its name, but I expect it to be in canSAR
We annotate compound synonyms. Try a chemical structure search. If data is missing, contact us at cansar@mdanderson.org.
How do I find out what tissues or cell lines show high expression of my target?
View the Target Synopsis and go to the Expression area. For multiple targets, use the expression tool.
How do I find out if there is half life or other ADME data for my compound?
This information can be obtained from the "Compound Synopsis" Page for a given compound.
Pricing Plans
Free
Free Plan• Access to integrated knowledge-base
• Machine learning predictions
• Chemical Search
• Advanced Search (Protein, Cell Lines, Drugs & Compounds, Diseases, 3D Structures, Protein Families)
• Insights on protein expression and drug bioactivity
• Regularly updated data
• Full functionality without license
Job Opportunities
There are currently no job postings for this AI tool.
Ratings & Reviews
No ratings available yet. Be the first to rate this tool!
Alternatives
X-Chem
X-Chem accelerates small molecule drug discovery by combining DEL technology with AI solutions. Their ArtemisAI platform powers HITMiner for molecular interaction mapping and hit expansion.
View Details
BenevolentAI
BenevolentAI uses AI for drug discovery and development, partnering with pharma companies to tackle complex diseases and accelerate drug development timelines.
View Details
Aitia Bio
Aitia Bio uses AI, multi-omic data, and Gemini Digital Twins to accelerate drug discovery and development, focusing on oncology and neurodegenerative diseases.
View Details
Aganitha AI
Aganitha AI is an in silico company that partners with biopharma, personal & homecare, and material sciences industries, leveraging AI to accelerate scientific R&D.
View Details
MindRank
Accelerate small molecule drug discovery and tackle hard-to-drug targets using a clinical-stage AI platform designed for biotech and pharmaceutical researchers.
View Details
Delta4
Identify new therapeutic indications for existing compounds using an AI-powered systems biology platform to reduce R&D costs and accelerate time-to-market.
View Details
ALS.ai
Accelerate ALS drug discovery and target identification using deep generative models and multi-omics data analysis to find novel therapeutics for patients.
View Details
Phenomic AI
Identify novel therapeutic targets for hard-to-treat solid tumors by using an ML-powered transcriptomics platform to analyze single-cell RNA and stromal biology.
View Details
biotx.ai
Help pharmaceutical researchers accelerate drug discovery and minimize clinical trial failure by mapping causal genetic links using AI-driven Mendelian randomization.
View Details
Proxima
Design programmable protein interactions and discover next-generation proximity-based medicines using an integrated AI platform for biopharmaceutical research.
View Details
Iktos
Accelerate drug discovery by integrating generative AI with automated robotics to design, synthesize, and test novel molecules in under two years for pharma teams.
View Details
Atomic AI
Accelerate RNA drug discovery using a foundation model that predicts 3D structures with atomic precision to unlock previously inaccessible therapeutic targets.
View Details
Iambic
Design superior therapeutic molecules and accelerate drug discovery using physics-based AI algorithms and high-throughput experimental feedback loops.
View Details
GSK.ai
Accelerate drug discovery and vaccine development by leveraging AI to interpret complex genetic datasets and understand the fundamental language of human cells.
View Details
Cognit
Accelerate functional genomics research and simulate complex gene regulatory networks using cross-species foundational AI models for in-silico cell engineering.
View Details
Gero
Extend healthy human lifespan and discover novel therapeutic targets using physics-informed AI models trained on over 100 million longitudinal medical records.
View Details
Receptor.AI
Optimize early-stage drug discovery for biotech researchers using an AI ecosystem that identifies cryptic binding sites and predicts over 80 ADMET endpoints.
View Details
Wisecube
Accelerate life sciences R&D using a foundational graph AI that unifies billions of biomedical data points to provide reliable, literature-backed insights.
View Details
Pending AI
Empower drug discovery teams to unlock difficult-to-drug targets and optimize lead candidates using quantum mechanical precision and trillion-scale generative AI.
View DetailsFeatured Tools
adly.news
Connect with engaged niche audiences or monetize your subscriber base through an automated marketplace featuring verified metrics and secure Stripe payments.
View Details
Nana Banana Pro
Maintain perfect character consistency across diverse scenes and styles with advanced AI-powered image editing for creators, marketers, and storytellers.
View Details
Kling 4.0
Transform text and images into cinematic 1080p videos with multi-shot storytelling, character consistency, and native lip-synced audio for professional creators.
View Details
AI Seedance
Generate 15-second cinematic 2K videos with physics-based audio and multi-shot narratives from text or images. Ideal for creators and marketing teams.
View Details
Mistrezz.AI
Engage in immersive NSFW roleplay and ASMR voice sessions with adaptive AI companions designed for structured escalation, fantasy scenarios, and personal connection.
View Details
Seedance 3.0
Transform text prompts or static images into professional 1080p cinematic videos. Perfect for creators and marketers seeking high-quality, physics-aware AI motion.
View Details
Seedance 3.0
Transform text descriptions into cinematic 4K videos instantly with ByteDance's advanced AI, offering professional-grade visuals for creators and marketing teams.
View Details
Seedance 2.0
Generate broadcast-quality 4K videos from simple text prompts with precise text rendering, high-fidelity visuals, and batch processing for content creators.
View Details
BeatViz
Create professional, rhythm-synced music videos instantly with AI-powered visual generation, ideal for independent artists, social media creators, and marketers.
View Details
Seedance 2.0
Generate cinematic 1080p videos from text or images using advanced motion synthesis and multi-shot storytelling for marketing, social media, and creators.
View Details
Seedream 5.0
Transform text descriptions into high-resolution 4K visuals and edit photos using advanced AI models designed for digital artists and e-commerce businesses.
View Details